Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 20;30(162):210122.
doi: 10.1183/16000617.0122-2021. Print 2021 Dec 31.

A role for club cells in smoking-associated lung adenocarcinoma

Affiliations
Review

A role for club cells in smoking-associated lung adenocarcinoma

Sabine J Behrend et al. Eur Respir Rev. .

Abstract

The cellular origin of lung adenocarcinoma remains a focus of intense research efforts. The marked cellular heterogeneity and plasticity of the lungs, as well as the vast variety of molecular subtypes of lung adenocarcinomas perplex the field and account for the extensive variability of experimental results. While most experts would agree on the cellular origins of other types of thoracic tumours, great controversy exists on the tumour-initiating cells of lung adenocarcinoma, since this histologic subtype of lung cancer arises in the distal pulmonary regions where airways and alveoli converge, occurs in smokers as well as nonsmokers, is likely caused by various environmental agents, and is marked by vast molecular and pathologic heterogeneity. Alveolar type II, club, and their variant cells have all been implicated in lung adenocarcinoma progeny and the lineage hierarchies in the distal lung remain disputed. Here we review the relevant literature in this rapidly expanding field, including results from mouse models and human studies. In addition, we present a case for club cells as cells of origin of lung adenocarcinomas that arise in smokers.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: S.J. Behrend has nothing to disclose. Conflict of interest: G.A. Giotopoulou has nothing to disclose. Conflict of interest: M. Spella has nothing to disclose. Conflict of interest: G.T. Stathopoulos has nothing to disclose.

References

    1. Bray F, Ferlay J, Soerjomataram I, et al. . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424. doi:10.3322/caac.21492 - DOI - PubMed
    1. Houston KA, Henley SJ, Li J, et al. . Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009. Lung Cancer 2014; 86: 22–28. doi:10.1016/j.lungcan.2014.08.001 - DOI - PMC - PubMed
    1. Kenfield SA, Wei EK, Stampfer MJ, et al. . Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control 2008; 17: 198–204. doi:10.1136/tc.2007.022582 - DOI - PMC - PubMed
    1. Minna JD, Schiller JH. Lung Cancer. In: Harrison's Principles of Internal Medicine. 17th Edn. MacGraw-Hill, Philadelphia, 2008; pp. 551–562.
    1. Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomarkers Prev 2019; 28: 1563–1579. doi:10.1158/1055-9965.EPI-19-0221 - DOI - PMC - PubMed